Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Jonathan A Gutman

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Gutman, Jonathan

One or more keywords matched the following items that are connected to Gutman, Jonathan

Item Type	Name
Academic Article	A novel CCAAT/enhancer binding protein a germline variant in a case of acute myeloid leukemia.
Academic Article	Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Academic Article	Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation.
Academic Article	Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.
Academic Article	Hematopoietic cell transplantation with cord blood for cure of HIV infections.
Concept	Leukemia, Myeloid, Acute
Concept	Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Academic Article	Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.
Academic Article	Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Academic Article	Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
Academic Article	Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Academic Article	Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Academic Article	Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.
Academic Article	Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
Academic Article	Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
Academic Article	Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.
Academic Article	Hypomethylating agents with venetoclax: have we discovered the holy grail?
Academic Article	Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.
Academic Article	Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.
Academic Article	The propriety of upgrading responses to venetoclax?+?azacitidine in newly diagnosed patients with acute myeloid leukemia.
Academic Article	Blood type change identifies late dominance reversal of chimerism after double umbilical cord blood transplantation with review of the literature.
Academic Article	Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Academic Article	Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.
Academic Article	Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax?+?Azacitidine Versus Intensive Chemotherapy.
Academic Article	Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.
Academic Article	How can we intervene to mitigate post-transplantation relapse in AML? Strategies to mitigate post-transplantation relapse in AML.
Academic Article	Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine.
Academic Article	Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Academic Article	Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.
Academic Article	Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine.

Search Criteria

Leukemia Myeloid